376253666	376253666	CD	B-NP	O
|	|	NN	I-NP	O
OH	OH	NN	I-NP	O
|	|	NN	I-NP	O
22342880	22342880	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2965634	2965634	CD	B-NP	O
|	|	CC	I-NP	O
10/20/2006	10/20/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2006	10/20/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/18/2006	5/18/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	B-protein
ADOLF	ADOLF	NNP	B-NP	I-protein
,	,	,	O	O
AVERY	AVERY	NNP	B-NP	O
C	C	NNP	I-NP	O
706-37-09-2	706-37-09-2	CD	I-NP	O
West	West	NNP	I-NP	O
Long	Long	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/4/06	10/4/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
SNF/rehab	SNF/rehab	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DUFFIE	DUFFIE	NNP	B-NP	O
,	,	,	O	O
MARIANO	MARIANO	NNP	B-NP	O
TAD	TAD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
CALTRATE	CALTRATE	NN	B-NP	O
600	600	CD	I-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
DUONEB	DUONEB	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
AND	AND	CC	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Wheezing	Wheeze	VBG	B-VP	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Insomnia	Insomnia	NNP	I-NP	I-protein
ATENOLOL	ATENOLOL	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
<	<	SYM	B-VP	I-protein
50	50	CD	B-NP	I-protein
BUSPAR	BUSPAR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
BUSPIRONE	BUSPIRONE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	B-NP	I-protein
15	15	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
ADVAIR	ADVAIR	NNP	I-NP	I-protein
DISKUS	DISKUS	NNP	I-NP	I-protein
500/50	500/50	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ON	ON	NNP	I-NP	O
8/4/06	8/4/06	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
10	10	CD	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
if	if	IN	B-SBAR	O
pt	pt	NN	B-NP	O
starts	start	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	O	O
increased	increase	VBN	B-NP	O
edema	edema	NN	I-NP	O
can	can	MD	B-VP	O
increase	increase	VB	I-VP	O
to	to	TO	B-PP	O
goal	goal	NN	B-NP	O
of	of	IN	B-PP	O
previous	previous	JJ	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
160	160	CD	B-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

NEURONTIN	NEURONTIN	NN	B-NP	B-protein
-LRB-	-LRB-	SYM	I-NP	O
GABAPENTIN	GABAPENTIN	NN	I-NP	O
-RRB-	-RRB-	SYM	O	O
100	100	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
oversedation	oversedation	NN	B-NP	O
VICODIN	VICODIN	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
HYDROCODONE	HYDROCODONE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
+	+	SYM	B-VP	O
APAP	APAP	NN	B-NP	O
500MG	500MG	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
1-2	1-2	CD	I-NP	O
TAB	TAB	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
NPO	NPO	NNP	B-NP	B-protein
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
SC	SC	NNP	I-NP	O
AC+HS	AC+HS	NNP	I-NP	O
Low	Low	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
Call	Call	NNP	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
DO	DO	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
supplemental	supplemental	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
Call	Call	VBP	B-VP	O
HO	HO	NN	B-NP	B-protein
if	if	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
350	350	CD	B-NP	O
Please	Please	NN	I-NP	O
give	give	VBP	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
standing	stand	VBG	B-VP	O
mealtime	mealtime	NN	B-NP	O
insulin	insulin	NN	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
NPO	NPO	NN	B-NP	B-protein
ATROVENT	ATROVENT	NN	I-NP	O
HFA	HFA	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	B-DNA
INH	INH	NN	I-NP	I-DNA
QID	QID	NN	I-NP	I-DNA
LORAZEPAM	LORAZEPAM	NN	I-NP	I-DNA
0.5	0.5	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
Q6H	Q6H	NN	I-NP	I-DNA
PRN	PRN	NN	I-NP	I-DNA
Anxiety	Anxiety	NN	I-NP	I-DNA
PREDNISONE	PREDNISONE	NN	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QAM	QAM	NN	I-NP	I-DNA
SEROQUEL	SEROQUEL	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
QUETIAPINE	QUETIAPINE	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
September	September	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
for	for	IN	B-PP	O
depression	depression	NN	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
ZOLOFT	ZOLOFT	NN	I-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SERTRALINE	SERTRALINE	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
125	125	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

TRAZODONE	TRAZODONE	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Appeling	Appeling	NNP	B-NP	O
at	at	IN	B-PP	O
DENDEP	DENDEP	NNP	B-NP	O
ME	ME	NNP	I-NP	O
GENERAL	GENERAL	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
1/5/06	1/5/06	CD	I-NP	O
1pm	1pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Masero	Masero	NNP	I-NP	O
at	at	IN	B-PP	O
BMC	BMC	NNP	B-NP	B-cell_type
in	in	IN	B-PP	O
Ertca	Ertca	NNP	B-NP	O
7/11/06	7/11/06	CD	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
50	50	CD	I-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Fibromyalgia	Fibromyalgia	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
fibromyalgia	fibromyalgia	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
DM	DM	NN	I-NP	O
Type	Type	NN	I-NP	O
II	II	CD	I-NP	O
asthma	asthma	NN	I-NP	O
obesity	obesity	NN	I-NP	O
depression	depression	NN	I-NP	O
ra	ra	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pud	pud	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
peptic	peptic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Generalized	Generalize	VBN	B-NP	O
pain	pain	NN	I-NP	O
**	**	SYM	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
64F	64F	NN	B-NP	O
with	with	IN	B-PP	O
20	20	CD	B-NP	O
year	year	NN	I-NP	O
h/o	h/o	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
OA	OA	NN	B-NP	B-protein
,	,	,	O	O
fibromyalgia	fibromyalgia	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
who	who	WP	B-NP	O
now	now	RB	B-ADVP	O
p/w	p/w	VBP	B-VP	O
11	11	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
greatly	greatly	RB	B-NP	O
increased	increase	VBN	I-NP	O
generalized	generalize	VBN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Unable	Unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
c/b	c/b	NN	I-NP	O
urinating	urinate	VBG	B-VP	O
and	and	CC	I-VP	O
stooling	stool	VBG	I-VP	O
on	on	IN	B-PP	O
bed	bed	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-ADJP	I-protein
not	not	RB	B-NP	I-protein
incontinent	incontinent	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
F/C/NS	F/C/NS	NNS	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-NP	O
grossly	grossly	RB	I-NP	O
positive	positive	JJ	I-NP	O
ROS	ROS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NOTE	NOTE	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
+	+	CC	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
palpable	palpable	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

SOB	SOB	NN	B-NP	B-protein
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

--	--	:	O	O
PMHx	PMHx	NN	B-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
diastolic	diastolic	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Cor	Cor	NNP	B-NP	O
pulmonale	pulmonale	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
,	,	,	O	O
Obesity	Obesity	NN	B-NP	O
,	,	,	O	O
H/o	H/o	NNP	B-NP	O
duodenal	duodenal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
Depression/Adjustment	Depression/Adjustment	NN	B-NP	O
Disorder	Disorder	NN	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
Home	Home	NNP	I-NP	O
Meds	Med	NNPS	I-NP	O
:	:	:	O	O
Dilaudid	Dilaudid	NNP	B-NP	O
2mg	2mg	CD	I-NP	O
Q4hr	Q4hr	NNP	I-NP	O
,	,	,	I-NP	O
Elavil	Elavil	NNP	I-NP	O
25mg	25mg	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Topamax	Topamax	NN	B-NP	O
100mg	100mg	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
60u	60u	IN	B-PP	O
QHS	QHS	NNP	B-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
10u	10u	CD	I-NP	O
AC	AC	NNP	I-NP	O
+	+	SYM	I-NP	O
SS	SS	NNP	I-NP	O
,	,	,	O	O
Advair/Atrovent/Duoneb	Advair/Atrovent/Duoneb	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
160	160	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
100	100	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
125	125	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Seroquel	Seroquel	NNP	B-NP	O
100	100	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Trazodone	Trazodone	NN	B-NP	B-protein
150	150	CD	B-NP	I-protein
qhs	qh	NNS	I-NP	I-protein
,	,	,	O	O
Buspar	Buspar	NNP	B-NP	O
15	15	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lorazepam	Lorazepam	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
Q4hr	Q4hr	NN	I-NP	O
prn	prn	NN	I-NP	O
--	--	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
Afeb	Afeb	NN	B-NP	O
74125/52	74125/52	CD	B-NP	O
18	18	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
RA	RA	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Morbidly	Morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
A	A	NNP	I-NP	O
&	&	CC	I-NP	O
O	O	NNP	I-NP	O
x3	x3	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
No	No	DT	B-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
skin	skin	NN	I-NP	O
breakdown	breakdown	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
non-focal	non-focal	JJ	B-ADJP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
diffusely	diffusely	RB	B-ADVP	O
.	.	.	O	O

--	--	:	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
--	--	:	O	O
Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
Generalized	Generalize	VBN	B-NP	O
pain	pain	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
and	and	CC	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
Polymyalgia	Polymyalgia	NNP	B-NP	O
rheumatica	rheumatica	NNP	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
pain	pain	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
pain	pain	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	I-VP	O
recommended	recommend	VBN	I-VP	O
using	use	VBG	B-VP	O
vicodin	vicodin	NN	B-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
dilaudid	dilaudid	NN	B-NP	O
and	and	CC	O	O
neurontin	neurontin	NN	B-NP	B-protein
rather	rather	RB	B-ADVP	O
that	that	DT	B-NP	O
topamax	topamax	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
rheumatology	rheumatology	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
obtained	obtain	VBN	B-NP	O
and	and	CC	I-NP	O
suggested	suggest	VBN	I-NP	O
starting	start	VBG	I-NP	O
prednisone	prednisone	NN	B-NP	O
10mg	10mg	CD	I-NP	O
qd	qd	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
PMR	PMR	NN	I-NP	O
with	with	IN	B-PP	O
close	close	JJ	B-ADJP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
rheumatologist	rheumatologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Dambrosi	Dambrosi	NNP	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
suggested	suggest	VBD	B-VP	O
starting	start	VBG	I-VP	O
calcium	calcium	NN	B-NP	O
+	+	SYM	I-NP	O
vitaminD	vitaminD	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
improved	improve	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
who	who	WP	B-NP	O
suggested	suggest	VBD	B-VP	O
rehab	rehab	NN	B-NP	O
placement	placement	NN	I-NP	O
for	for	IN	B-PP	O
deconditioning	deconditioning	NN	B-NP	O
and	and	CC	I-NP	O
inability	inability	NN	I-NP	O
to	to	TO	B-VP	O
care	care	VB	I-VP	O
for	for	IN	B-PP	O
herself	herself	PRP	B-NP	O
.	.	.	O	O

**	**	SYM	O	O
Renal	Renal	JJ	O	O
:	:	:	O	O
During	During	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
new	new	JJ	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
decreased	decrease	VBN	B-NP	O
PO	PO	NN	I-NP	O
intake	intake	NN	I-NP	O
of	of	IN	B-PP	O
fluids	fluid	NNS	B-NP	O
and	and	CC	O	O
continuation	continuation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
of	of	IN	B-PP	O
160qd	160qd	CD	B-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
then	then	RB	B-ADVP	O
stated	state	VBD	B-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
pre-renal	pre-renal	JJ	I-NP	O
state	state	NN	I-NP	O
and	and	CC	O	O
resolved	resolve	VBN	B-VP	O
completely	completely	RB	B-ADVP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
Depression	Depression	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
elavil	elavil	NN	B-NP	O
,	,	,	O	O
seroquel	seroquel	NN	B-NP	O
,	,	,	O	O
zoloft	zoloft	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
buspar	buspar	NN	B-NP	O
.	.	.	O	O

**	**	SYM	O	O
Diabetes	Diabetes	NNP	B-NP	O
Mellitus	Mellitus	NNP	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
PLease	PLease	NN	B-NP	O
return	return	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
dr.	dr.	NN	B-NP	O
Matheu	Matheu	NNP	I-NP	O
in	in	IN	B-PP	O
June	June	NNP	B-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Dunman	Dunman	NNP	I-NP	O
No	No	NNP	I-NP	O
dictated	dictate	VBD	B-VP	O
summary	summary	JJ	B-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SHARPLIN	SHARPLIN	NNP	B-NP	O
,	,	,	O	O
BRENTON	BRENTON	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CV88	CV88	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/4/06	10/4/06	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
33	33	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

